BPMUF
Price
$52.83
Change
+$1.57 (+3.06%)
Updated
Oct 11 closing price
GTBP
Price
$1.75
Change
-$0.17 (-8.85%)
Updated
Dec 20 closing price
Ad is loading...

BPMUF vs GTBP

Header iconBPMUF vs GTBP Comparison
Open Charts BPMUF vs GTBPBanner chart's image
Basilea Pharmaceutica AG
Price$52.83
Change+$1.57 (+3.06%)
Volume$135
CapitalizationN/A
GT Biopharma
Price$1.75
Change-$0.17 (-8.85%)
Volume$86.83K
CapitalizationN/A
BPMUF vs GTBP Comparison Chart
Loading...
BPMUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GTBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPMUF vs. GTBP commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMUF is a Buy and GTBP is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (BPMUF: $52.83 vs. GTBP: $1.75)
Brand notoriety: BPMUF and GTBP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMUF: 100% vs. GTBP: 300%
Market capitalization -- BPMUF: $561.52M vs. GTBP: $3.95M
BPMUF [@Biotechnology] is valued at $561.52M. GTBP’s [@Biotechnology] market capitalization is $3.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMUF’s FA Score shows that 1 FA rating(s) are green whileGTBP’s FA Score has 1 green FA rating(s).

  • BPMUF’s FA Score: 1 green, 4 red.
  • GTBP’s FA Score: 1 green, 4 red.
According to our system of comparison, BPMUF is a better buy in the long-term than GTBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMUF’s TA Score shows that 1 TA indicator(s) are bullish while GTBP’s TA Score has 4 bullish TA indicator(s).

  • BPMUF’s TA Score: 1 bullish, 0 bearish.
  • GTBP’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BPMUF is a better buy in the short-term than GTBP.

Price Growth

BPMUF (@Biotechnology) experienced а 0.00% price change this week, while GTBP (@Biotechnology) price change was -36.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

GTBP is expected to report earnings on May 13, 2024.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMUF($562M) has a higher market cap than GTBP($3.95M). BPMUF YTD gains are higher at: 28.854 vs. GTBP (-77.190). BPMUF has higher annual earnings (EBITDA): -4.5M vs. GTBP (-12.35M). BPMUF has more cash in the bank: 63M vs. GTBP (6.42M). GTBP has less debt than BPMUF: GTBP (0) vs BPMUF (112M). BPMUF has higher revenues than GTBP: BPMUF (149M) vs GTBP (0).
BPMUFGTBPBPMUF / GTBP
Capitalization562M3.95M14,246%
EBITDA-4.5M-12.35M36%
Gain YTD28.854-77.190-37%
P/E Ratio51.42N/A-
Revenue149M0-
Total Cash63M6.42M982%
Total Debt112M0-
FUNDAMENTALS RATINGS
BPMUF vs GTBP: Fundamental Ratings
BPMUF
GTBP
OUTLOOK RATING
1..100
5051
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9199
PRICE GROWTH RATING
1..100
4794
P/E GROWTH RATING
1..100
32100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GTBP's Valuation (29) in the null industry is somewhat better than the same rating for BPMUF (89). This means that GTBP’s stock grew somewhat faster than BPMUF’s over the last 12 months.

GTBP's Profit vs Risk Rating (100) in the null industry is in the same range as BPMUF (100). This means that GTBP’s stock grew similarly to BPMUF’s over the last 12 months.

BPMUF's SMR Rating (91) in the null industry is in the same range as GTBP (99). This means that BPMUF’s stock grew similarly to GTBP’s over the last 12 months.

BPMUF's Price Growth Rating (47) in the null industry is somewhat better than the same rating for GTBP (94). This means that BPMUF’s stock grew somewhat faster than GTBP’s over the last 12 months.

BPMUF's P/E Growth Rating (32) in the null industry is significantly better than the same rating for GTBP (100). This means that BPMUF’s stock grew significantly faster than GTBP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BPMUFGTBP
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
78%
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
18%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
13%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 13 days ago
87%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 6 days ago
17%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
BPMUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GTBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOI0.21N/A
+1.55%
Oncology Institute (The)
CMPR74.210.51
+0.69%
Cimpress plc
VEL20.23-0.19
-0.93%
Velocity Financial
KEP7.14-0.07
-0.97%
Korea Electric Power Corp
ATXI1.77-0.03
-1.67%
Avenue Therapeutics

BPMUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMUF has been loosely correlated with AAVXF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMUF jumps, then AAVXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMUF
1D Price
Change %
BPMUF100%
N/A
AAVXF - BPMUF
47%
Loosely correlated
N/A
ABCZF - BPMUF
38%
Loosely correlated
N/A
ALZN - BPMUF
36%
Loosely correlated
-11.20%
GTBP - BPMUF
29%
Poorly correlated
-9.11%
NCNA - BPMUF
28%
Poorly correlated
N/A
More

GTBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, GTBP has been loosely correlated with PTCT. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GTBP jumps, then PTCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTBP
1D Price
Change %
GTBP100%
-9.11%
PTCT - GTBP
35%
Loosely correlated
+2.19%
AMRN - GTBP
33%
Poorly correlated
-1.18%
MDGL - GTBP
32%
Poorly correlated
+5.12%
VKTX - GTBP
31%
Poorly correlated
+1.83%
BPMUF - GTBP
29%
Poorly correlated
N/A
More